MediPharm Labs Corp. (LABS) Reports 18% Sequential Revenue Growth and Positive Net Income

MediPharm Labs reported Q3 2026 revenue up 18% from Q2 2026, with revenue, gross profit and Adjusted EBITDA higher than Q3 2025. It reported positive net income for a second consecutive quarter and positive Adjusted EBITDA for a third.Material DetailsContext by AI AnalystThis is an early confirmati…